[RNAZ] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
15-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -33.84%
YoY- -178.60%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
Revenue 0 0 0 0 0 -
PBT -5,191 -4,342 -4,671 2,771 -127 152.68%
Tax -0 789 -36 -3,126 -0 -
NP -5,191 -4,342 -4,635 5,897 -127 152.68%
Tax Rate - - - 112.83% - -
Total Cost 5,191 4,342 4,635 -5,897 127 152.68%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 CAGR
EPS -0.74 -135.68 -289.70 589.73 -15.94 -53.55%
EPS Diluted -0.74 -131.61 -285.73 589.73 -15.94 -53.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.